RE:Breaking down badly juniorbullalive wrote: Is there a risk of an FDA rejection ?
May of 2020 was a good month for MDNA. The share price ran up to the 52 week high of $7.25 by the end of May. Since then it has been primarily a $5 to $5.50 stock price and over the past month has been totally beaten down to the low $4 range -- $4.13 today.
Not sure why it is so depressed but some good news would probably help and that would have to be something other than attending another zoom conference. I would estimate that about 12 of the last 16 news items over the past 6 months have been re attending conferences.
A good old fashioned news release regarding achieving some new objective or standard is what is needed.